MENU
MIRM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mirum Pharmaceuticals (MIRM) Earnings Date & Reports
Mirum Pharmaceuticals Inc... Show more
A.I. Advisor
published Earnings
MIRM is expected to report earnings to fall 50.40% to -52 cents per share on November 17
Q3'26
Est.
$-0.53
Q2'26
Missed
by $0.32
Q1'26
Missed
by $13.09
Q4'25
Missed
by $0.08
Q3'25
Beat
by $0.20
The last earnings report on August 05 showed earnings per share of -105 cents, missing the estimate of -74 cents. With 229.45K shares outstanding, the current market capitalization sits at 6.38B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
Industry Biotechnology
Profile
Details
Industry
N/A
Address
989 East Hillsdale Boulevard
Phone
+1 650 667-4085
Employees
372
Web
https://www.mirumpharma.com